HEADER TRANSFERASE/TRANSFERASE INHIBITOR 17-MAR-15 4YTI TITLE DISCOVERY OF VX-509 (DECERNOTINIB): A POTENT AND SELECTIVE JANUS TITLE 2 KINASE (JAK) 3 INHIBITOR FOR THE TREATMENT OF AUTOIMMUNE DISEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 842-1132; COMPND 5 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS JANUS KINASE, JAK2, JAK3, KINASE, INHIBITOR, AUTOIMMUNE, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.J.ZUCCOLA,M.LEDEBOER REVDAT 5 16-OCT-24 4YTI 1 JRNL REMARK HETSYN REVDAT 4 07-OCT-15 4YTI 1 JRNL REVDAT 3 23-SEP-15 4YTI 1 JRNL REVDAT 2 19-AUG-15 4YTI 1 REMARK REVDAT 1 12-AUG-15 4YTI 0 JRNL AUTH L.J.FARMER,M.W.LEDEBOER,T.HOOCK,M.J.ARNOST,R.S.BETHIEL, JRNL AUTH 2 Y.L.BENNANI,J.J.BLACK,C.L.BRUMMEL,A.CHAKILAM,W.A.DORSCH, JRNL AUTH 3 B.FAN,J.E.COCHRAN,S.HALAS,E.M.HARRINGTON,J.K.HOGAN,D.HOWE, JRNL AUTH 4 H.HUANG,D.H.JACOBS,L.M.LAITINEN,S.LIAO,S.MAHAJAN,V.MARONE, JRNL AUTH 5 G.MARTINEZ-BOTELLA,P.MCCARTHY,D.MESSERSMITH,M.NAMCHUK,L.OH, JRNL AUTH 6 M.S.PENNEY,A.C.PIERCE,S.A.RAYBUCK,A.RUGG,F.G.SALITURO, JRNL AUTH 7 K.SAXENA,D.SHANNON,D.SHLYAKTER,L.SWENSON,S.K.TIAN,C.TOWN, JRNL AUTH 8 J.WANG,T.WANG,M.W.WANNAMAKER,R.J.WINQUIST,H.J.ZUCCOLA JRNL TITL DISCOVERY OF VX-509 (DECERNOTINIB): A POTENT AND SELECTIVE JRNL TITL 2 JANUS KINASE 3 INHIBITOR FOR THE TREATMENT OF AUTOIMMUNE JRNL TITL 3 DISEASES. JRNL REF J.MED.CHEM. V. 58 7195 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26230873 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00301 REMARK 2 REMARK 2 RESOLUTION. 2.52 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.52 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 11356 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 545 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.52 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.33 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2621 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2264 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2491 REMARK 3 BIN R VALUE (WORKING SET) : 0.2248 REMARK 3 BIN FREE R VALUE : 0.2607 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.96 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 130 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2375 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 37 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.48 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 10.56620 REMARK 3 B22 (A**2) : -8.21050 REMARK 3 B33 (A**2) : -2.35570 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.681 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.251 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.660 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.254 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.910 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.896 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2472 ; 1.000 ; HARMONIC REMARK 3 BOND ANGLES : 3335 ; 1.000 ; HARMONIC REMARK 3 TORSION ANGLES : 898 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 72 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 366 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2472 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 297 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2694 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.44 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.36 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4YTI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-MAR-15. REMARK 100 THE DEPOSITION ID IS D_1000208084. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11356 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.520 REMARK 200 RESOLUTION RANGE LOW (A) : 50.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.7-2.1 DL-MALIC ACID PH 7.0, 2MM DTT, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.20350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.20350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 47.46600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.49050 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 47.46600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.49050 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 34.20350 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 47.46600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 50.49050 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 34.20350 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 47.46600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 50.49050 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 837 REMARK 465 SER A 838 REMARK 465 HIS A 839 REMARK 465 ASN A 840 REMARK 465 MET A 841 REMARK 465 ALA A 920 REMARK 465 GLY A 921 REMARK 465 ARG A 922 REMARK 465 ALA A 1131 REMARK 465 GLY A 1132 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 860 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 993 N - CA - C ANGL. DEV. = 17.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 859 70.10 -53.22 REMARK 500 ASP A 869 74.08 -117.55 REMARK 500 LYS A 945 -132.51 28.17 REMARK 500 ARG A 975 -6.88 69.78 REMARK 500 ASP A 994 104.18 45.15 REMARK 500 TRP A1106 37.76 -88.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VJK A 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4YTC RELATED DB: PDB REMARK 900 RELATED ID: 4YTF RELATED DB: PDB REMARK 900 RELATED ID: 4YTH RELATED DB: PDB DBREF 4YTI A 842 1132 UNP O60674 JAK2_HUMAN 842 1132 SEQADV 4YTI GLY A 837 UNP O60674 EXPRESSION TAG SEQADV 4YTI SER A 838 UNP O60674 EXPRESSION TAG SEQADV 4YTI HIS A 839 UNP O60674 EXPRESSION TAG SEQADV 4YTI ASN A 840 UNP O60674 EXPRESSION TAG SEQADV 4YTI MET A 841 UNP O60674 EXPRESSION TAG SEQRES 1 A 296 GLY SER HIS ASN MET THR GLN PHE GLU GLU ARG HIS LEU SEQRES 2 A 296 LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER SEQRES 3 A 296 VAL GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR SEQRES 4 A 296 GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR SEQRES 5 A 296 GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE SEQRES 6 A 296 LEU LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS SEQRES 7 A 296 GLY VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU SEQRES 8 A 296 ILE MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR SEQRES 9 A 296 LEU GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU SEQRES 10 A 296 LEU GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR SEQRES 11 A 296 LEU GLY THR LYS ARG TYR ILE HIS ARG ASP LEU ALA THR SEQRES 12 A 296 ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE SEQRES 13 A 296 GLY ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS SEQRES 14 A 296 GLU PTR PTR LYS VAL LYS GLU PRO GLY GLU SER PRO ILE SEQRES 15 A 296 PHE TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SEQRES 16 A 296 SER VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU SEQRES 17 A 296 TYR GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO SEQRES 18 A 296 PRO ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN SEQRES 19 A 296 GLY GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS SEQRES 20 A 296 ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP SEQRES 21 A 296 GLU ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN SEQRES 22 A 296 VAL ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG SEQRES 23 A 296 VAL ASP GLN ILE ARG ASP ASN MET ALA GLY MODRES 4YTI PTR A 1007 TYR MODIFIED RESIDUE MODRES 4YTI PTR A 1008 TYR MODIFIED RESIDUE HET PTR A1007 16 HET PTR A1008 16 HET VJK A4000 28 HETNAM PTR O-PHOSPHOTYROSINE HETNAM VJK (2R)-2-METHYL-2-[[2-(1H-PYRROLO[2,3-B]PYRIDIN-3-YL) HETNAM 2 VJK PYRIMIDIN-4-YL]AMINO]-N-[2,2,2-TRIS(FLUORANYL) HETNAM 3 VJK ETHYL]BUTANAMIDE HETSYN PTR PHOSPHONOTYROSINE HETSYN VJK DECERNOTINIB; ADELATINIB; VX-509 FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 VJK C18 H19 F3 N6 O FORMUL 3 HOH *37(H2 O) HELIX 1 AA1 GLU A 845 ARG A 847 5 3 HELIX 2 AA2 THR A 888 LEU A 905 1 18 HELIX 3 AA3 SER A 936 LYS A 945 1 10 HELIX 4 AA4 GLU A 946 ILE A 948 5 3 HELIX 5 AA5 ASP A 949 LYS A 970 1 22 HELIX 6 AA6 ALA A 978 ARG A 980 5 3 HELIX 7 AA7 PRO A 1017 TYR A 1021 5 5 HELIX 8 AA8 ALA A 1022 SER A 1029 1 8 HELIX 9 AA9 SER A 1032 THR A 1049 1 18 HELIX 10 AB1 GLU A 1052 LYS A 1055 5 4 HELIX 11 AB2 SER A 1056 GLY A 1066 1 11 HELIX 12 AB3 GLY A 1071 ASN A 1084 1 14 HELIX 13 AB4 PRO A 1095 TRP A 1106 1 12 HELIX 14 AB5 ASN A 1109 ARG A 1113 5 5 HELIX 15 AB6 SER A 1115 MET A 1130 1 16 SHEET 1 AA1 5 LEU A 849 LYS A 857 0 SHEET 2 AA1 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 AA1 5 GLU A 877 LEU A 884 -1 O GLU A 877 N TYR A 868 SHEET 4 AA1 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 AA1 5 TYR A 913 CYS A 917 -1 N GLY A 915 O ILE A 928 SHEET 1 AA2 2 TYR A 972 ILE A 973 0 SHEET 2 AA2 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AA3 2 ILE A 982 ASN A 986 0 SHEET 2 AA3 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 AA4 2 PTR A1008 LYS A1009 0 SHEET 2 AA4 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.34 LINK C PTR A1007 N PTR A1008 1555 1555 1.34 LINK C PTR A1008 N LYS A1009 1555 1555 1.34 SITE 1 AC1 14 GLY A 856 VAL A 863 ALA A 880 GLU A 930 SITE 2 AC1 14 TYR A 931 LEU A 932 GLY A 935 ARG A 980 SITE 3 AC1 14 ASN A 981 ILE A 982 LEU A 983 GLY A 993 SITE 4 AC1 14 ASP A 994 HOH A4137 CRYST1 94.932 100.981 68.407 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010534 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009903 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014618 0.00000